Read or download the official PDF of this gazette notification issued by the Ministry of Chemicals and Fertilizers :
Department of Pharmaceuticals on 8th August 2026. Classified under Press Release.
Executive Summary
Union Minister J.P. Nadda released a knowledge paper titled "AI in MedTech: Revolutionizing Healthcare Through Artificial Intelligence" on August 8, 2026, at the 9th Edition of India Medical Device 2026. Developed by Praxis Global Alliance and FICCI, the report outlines five strategic priorities to transition AI solutions from successful pilots to large-scale clinical adoption. It emphasizes the necessity of coordinated action across government, industry, and academia to establish India as a global leader in responsible AI-enabled medical technologies.
Key Points / Main Content
Current Landscape and Foundations
India utilizes existing foundations such as the Ayushman Bharat Digital Mission (ABDM), IndiaAI Mission, SAHI, BODH, and the National Medical Devices Policy, 2023.
MedTech is identified as India's most immediate and scalable AI opportunity, capable of embedding specialist expertise directly into medical devices.
India possesses unique advantages for AI leadership, including strong software capabilities, digital public infrastructure, and a growing MedTech manufacturing base.
Barriers to Adoption
Large-scale clinical adoption is currently hindered by fragmented health data and limited evidence.
The ecosystem faces constraints from evolving regulations and a lack of established reimbursement pathways that recognize AI-enabled value.
There is a critical need to bridge the gap between successful pilot projects and routine clinical use.
Strategic Priorities and Applications
Regulatory Reform: Development of predictable, lifecycle-based regulations for adaptive AI is required.
Infrastructure: Establishing AI-ready data and evidence remains a top priority for scaling.
Economic Mechanisms: Creation of supportive procurement and reimbursement mechanisms to incentivize AI adoption.
Targeted Applications: AI-enabled diagnostics are expected to be the first large-scale application, aimed at reducing healthcare inequities and improving productivity in primary and secondary care.
Impact Analysis
Government and RegulatorsImpact
They are responsible for shaping the policy environment that currently faces gaps in regulation and procurement.
Action Required
Develop predictable lifecycle-based regulations for adaptive AI and establish procurement mechanisms that recognize the value of AI-enabled technologies.
MedTech Industry and ManufacturersImpact
The sector has the opportunity to leverage India's manufacturing base to become a global leader in AI-enabled medical technologies.
Action Required
Focus on moving AI solutions from pilots to large-scale deployment and collaborate with the ecosystem to provide necessary data and evidence.
Healthcare Providers (Clinicians and Hospitals)Impact
Providers will gain access to specialist expertise through AI-enabled diagnostics and clinical decision support, particularly in primary and secondary care.
Action Required
Adopt AI-enabled medical devices into routine clinical practice and participate in creating a culture of acceptance for AI-driven healthcare solutions.
Payers and Industry StakeholdersImpact
The lack of limited reimbursement pathways currently constrains the growth of AI adoption.
Action Required
Coordinate with the government and industry to create supportive reimbursement frameworks that account for the clinical value of AI.
Key Entities Referenced
AI in MedTech: Revolutionizing Healthcare Through Artificial Intelligence: The primary knowledge paper outlining strategic actions and five key priorities for accelerating responsible AI adoption in India's healthcare and medical device sectors.
J. P. Nadda: Union Minister of Chemicals & Fertilizers and Health & Family Welfare who released the report and advocates for moving AI solutions from pilots to large-scale clinical adoption.
Department of Pharmaceuticals: The primary government department that organized the India Medical Device 2026 event and oversees the MedTech landscape and regulatory interventions.
National Medical Devices Policy, 2023: A referenced foundational policy document that provides the framework for India's evolving AI-enabled medical technology sector.
Ayushman Bharat Digital Mission (ABDM): A core national digital health initiative identified as a critical foundation for building AI-driven healthcare infrastructure in India.
Ministry of Chemicals and Fertilizers :
Department of Pharmaceuticals
Union Minister J P Nadda releases Knowledge
Paper on ‘AI in MedTech: Revolutionizing
Healthcare Through Artificial Intelligence’
Report Outlines Five Key Priorities for Accelerating
Responsible AI Adoption in Healthcare
प्रव तथ: 08 AUG 2026 5:52PM by PIB Delhi
Union Minister of Chemicals & Fertilizers and Health & Family Welfare Shri J. P. Nadda, released a
knowledge paper on "AI in MedTech: Revolutionizing Healthcare Through Artificial Intelligence"
today at the 9th Edition of India Medical Device 2026, organized by the Department of Pharmaceuticals in
association with FICCI, at Vigyan Bhawan, New Delhi. The report highlights the growing role of Artificial
Intelligence (AI) in the healthcare sector, from creating new opportunities to addressing emerging
challenges.
Jointly developed by Praxis Global Alliance, in association with FICCI, the knowledge paper examines
India's evolving AI-enabled MedTech landscape and outlines the strategic actions needed to accelerate
responsible AI adoption across healthcare. It explores AI's role in diagnostics, clinical decision support,
operational efficiency and medical device innovation, while identifying the regulatory, policy and
ecosystem interventions required to enable large-scale adoption. The report while noting that India has
already built important foundations through the Ayushman Bharat Digital Mission (ABDM), the IndiaAI
Mission, SAHI, BODH and the National Medical Devices Policy, 2023, observes that moving AI solutions
from successful pilots to large-scale clinical adoption is a major challenge.The report notes that this transition requires addressing fragmented health data and limited evidence,
developing predictable lifecycle-based regulation for adaptive AI, and creating supportive reimbursement
and procurement mechanisms. It says, India also has a unique opportunity to leverage its software
capabilities, digital public infrastructure, clinical diversity and growing MedTech manufacturing base to
become a global leader in the responsible development, manufacturing and deployment of AI-enabled
medical technologies.
Shri Manoj Joshi, Secretary, Department of Pharmaceuticals; Dr.M Srinivas, Member, NITI Aayog; Dr
Rajiv Bahl, Secretary, Department of Health Research & Director General, ICMR; Smt. Punya Salila
Srivastava, Secretary, Department of Health and Family Welfare; Shri Amardeep Singh Bhatia,
Secretary, Department of Promotion of Industry & Internal Trade (DPIIT); Shri Sunil Kumar Barnwal,
CEO, National Health Authority; Shri Anant Swarup, Secretary General, FICCI; and senior government
officials, industry leaders and stakeholders from the MedTech sector were present on the occasion.
Key insights from the knowledge paper
The report highlights five priorities for accelerating AI-enabled MedTech adoption in India:
• MedTech represents India's most immediate and scalable AI opportunity, enabling specialist
expertise to be embedded directly into medical devices and expanding access to quality healthcare
• India has the foundations for AI leadership, but not yet the ecosystem for scale. While digital
infrastructure, innovation and clinician acceptance have advanced rapidly, AI adoption remains
constrained by fragmented data, evolving regulation and limited reimbursement pathways
• India must move beyond successful pilots to routine clinical adoption by addressing three
ecosystem gaps: AI-ready data and evidence, lifecycle-based regulation, and procurement and
reimbursement mechanisms that recognise AI-enabled value
• AI-enabled diagnostics are expected to be the first large-scale application, helping extend
specialist expertise to primary and secondary care, improve productivity and reduce inequities in
healthcare access
• Coordinated action across government, regulators, healthcare providers, payers, industry and
academia will be essential to position India as a global leader in responsible AI-enabled MedTech
Full report can be accessed here
****
PC/PM
(रलीज़ आईडी: 2296569) आगंतुक पटल : 2190
इस वज्ञ को इन भाषाओ ंम पढ़: Telugu , Urdu , ही